BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7285326)

  • 1. Plasma lipid-bound sialic acid and carcinoembryonic antigen in cancer patients.
    Dnistrian AM; Schwartz MK
    Clin Chem; 1981 Oct; 27(10):1737-9. PubMed ID: 7285326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-bound sialic acid as a tumor marker.
    Dnistrian AM; Schwartz MK
    Ann Clin Lab Sci; 1983; 13(2):137-42. PubMed ID: 6859805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid bound sialic acid in cancer patients.
    Salvagno L; Ferrazzi E; Sileni VC; Maggi S; Tredese F; Bedendo C; Russo MP; Fiorentino MV; Ceriotti G
    Tumori; 1985 Apr; 71(2):127-33. PubMed ID: 4002346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of plasma lipid-bound sialic acid (LBSA) and carcinoembryonic antigen (CEA) in gynaecologic cancer patients.
    Tredese F; Maggino T; Salvagno L; Marchesoni D; Chizzolini M; Pattaro RF
    Eur J Gynaecol Oncol; 1985; 6(2):136-8. PubMed ID: 4029198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of lipid-associated sialic acid (LASA or LSA) as a serum marker for malignancy. A review of the literature.
    Schutter EM; Visser JJ; van Kamp GJ; Mensdorff-Pouilly S; van Dijk W; Hilgers J; Kenemans P
    Tumour Biol; 1992; 13(3):121-32. PubMed ID: 1626178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined measurement and significance of lipid-bound sialic acid and carcinoembryonic antigen in detection of human cancer.
    Munjal DD; Picken J; Pritchard J
    Diagn Immunol; 1984; 2(1):36-43. PubMed ID: 6499373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study of serum lipid-bound sialic acid and carcinoembryonic antigen in patients with lung cancer].
    Zhu X
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Feb; 13(1):25-7, 61. PubMed ID: 2165867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Behavior of serum sialic acid levels at various stages of neoplastic disease].
    Adamo V; Altavilla G; Caristi N; Chillemi S; Giacobello T; Scalisi R; Palmara D
    Minerva Med; 1985 Nov; 76(43):2067-70. PubMed ID: 4069416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum sialic acid (TSA/LSA) and carcinoembryonic antigen (CEA) levels in cancer patients undergoing radiotherapy.
    Stringou E; Chondros K; Kouvaris J; Kakari S; Papavassiliou K
    Anticancer Res; 1992; 12(1):251-5. PubMed ID: 1567173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid-associated sialic acid test for the detection of human cancer.
    Katopodis N; Hirshaut Y; Geller NL; Stock CC
    Cancer Res; 1982 Dec; 42(12):5270-5. PubMed ID: 7139630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The determination of sialic acid in cancer patients].
    Correale M; Abbate I; Gargano G; Catino A; Musci MD; Dragone CD; De Lena M
    Minerva Med; 1992; 83(7-8):427-31. PubMed ID: 1522966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use and limitations of serum total and lipid-bound sialic acid concentrations as markers for colorectal cancer.
    Erbil KM; Jones JD; Klee GG
    Cancer; 1985 Jan; 55(2):404-9. PubMed ID: 3965096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relation between lipid-bound sialic acid in blood serum and plasma andin human tumors].
    Polívková J; Vosmiková K; Pospísil J; Poucková P
    Bratisl Lek Listy; 1992 May; 93(5):222-4. PubMed ID: 1393642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five tumor markers in lung cancer: significance of total and "lipid"-bound sialic acid.
    Kakari S; Stringou E; Toumbis M; Ferderigos AS; Poulaki E; Chondros K; Dema A; Kotsovoulou V; Pavlidis N
    Anticancer Res; 1991; 11(6):2107-10. PubMed ID: 1663720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sialic acid levels in various types of cancer.
    Kökoğlu E; Sönmez H; Uslu E; Uslu I
    Cancer Biochem Biophys; 1992 Oct; 13(1):57-64. PubMed ID: 1343847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma sialic acid alterations in neoplastic diseases.
    Dwivedi C; Dixit M; Kumar SS; Reddy H; Semenya KA; Hardy RE
    J Med; 1987; 18(5-6):323-32. PubMed ID: 3505259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum sialic acid and CEA concentrations in human breast cancer.
    Hogan-Ryan A; Fennelly JJ; Jones M; Cantwell B; Duffy MJ
    Br J Cancer; 1980 Apr; 41(4):587-92. PubMed ID: 7387856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sialic acid and carcinoembryonic antigen (CEA) as markers of colon cancer: Preliminary report].
    Dabrowska B; Krasnodebski IW; Tadeusiak W
    Pol Tyg Lek; 1991 Nov 11-25; 46(45-47):890-1. PubMed ID: 1669462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of lipid-bound sialic acid (LSA) as a tumor marker.
    López Sáez JJ; Senra-Varela A
    Int J Biol Markers; 1995; 10(3):174-9. PubMed ID: 8551061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma lipid-bound sialic acid alterations in neoplastic diseases.
    Dwivedi C; Dixit M; Hardy RE
    Experientia; 1990 Jan; 46(1):91-4. PubMed ID: 2298288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.